Key Insights

Highlights

Treatment Research

5 treatments under study, led by Antiplaque

Research Leaders

5 sponsors active, led by Solventum US LLC

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 90/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Recruiting2
Not Yet Recruiting1
Terminated1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07390188Recruiting

Prevalence of Oral Mucosal Lesions Among a Sample of Adult Egyptian Subjects

NCT06942026Phase 4Not Yet RecruitingPrimary

Effects of Chlorhexidine Gluconate, Ozonated Water and Hypochlorous Acid Solutions Used in the Oral Care of Patients Supported by Mechanical Ventilation on the Integrity of the Oral Mucosa

NCT06732609RecruitingPrimary

Perioral Tissue Evaluation With Advanced Videodermoscopy (FAV)

NCT04601103Not ApplicableTerminatedPrimary

3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes

Showing all 4 trials

Research Network

Common Treatments

  • Antiplaque1
  • No Sls Toothpaste1
  • High Sls Toothpaste1
  • Control 11
  • Medium Sls Toothpaste1

Active Sponsors

  • Solventum US LLC1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
  • Aydin Adnan Menderes University1
  • 3M1
  • Cairo University1

Top Investigators

Related Conditions

  • Oral Mucosal Disease1

Activity Timeline